Month: June 2025

Key Takeaways Price hikes, not launch prices, drove the GTN bubble. The real driver of the gross-to-net (GTN) bubble was the pharmaceutical industry’s ability to raise drug prices year after year—enabled by loopholes in PBM contracts—rather than high launch prices alone. PBMs enabled the bubble through rebate structures. PBMs often profited from list price increases […]

Sticker shock at the pharmacy counter has become an all-too-familiar experience for both patients and providers. The rising cost of prescription medications in the United States creates a growing obstacle for millions of people. In 2022, more than 4,200 drug products experienced price increases (many of which were higher than the rate of inflation), compared […]

In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology into pharmaceutical packaging to enhance product identification, tracking, and patient engagement. She explains that packaging primarily involves embedding technologies such as RFID radio-frequency identification (RFID) or Bluetooth low energy (BLE) into pharmaceutical containers. These technologies […]

Image Credit: Adobe Stock Images/Tippapatt.com Key Takeaways DHL has acquired Cryoport’s specialty courier business, CRYOPDP, for approximately $200 million, strengthening its position in temperature-controlled logistics for the life sciences sector. A strategic partnership between DHL and Cryoport has been formed to enhance global supply chain capabilities, particularly in the APAC and EMEA regions. DHL is […]

In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology into pharmaceutical packaging to enhance product identification, tracking, and patient engagement. She explains that packaging primarily involves embedding technologies such as RFID radio-frequency identification (RFID) or Bluetooth low energy (BLE) into pharmaceutical containers. These technologies […]

Image Credit: Adobe Stock Images/BeaunittaVanWyk.com Key Takeaways Alzheimer’s disease affects nearly 6.9 million older U.S. adults, making it the most common form of dementia and a leading cause of long-term care needs and disability. The economic burden of ADRD is substantial and rising, with costs projected to increase from nearly $344 billion in 2020 to […]

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the US population affected, the issue is increasingly urgent, particularly as major chains like Rite Aid […]

Image Credit: Adobe Stock Images/Nattakorn.com Key Takeaways Language barriers reduce access to video-based virtual care: Adult patients facing language barriers are significantly less likely to use video visits compared to telephone visits, especially in specialist care settings. Overall virtual care use isn’t drastically different: There is no significant difference in the overall use of virtual […]

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the US population affected, the issue is increasingly urgent, particularly as major chains like Rite Aid […]

Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV season and avoid past shortages. Sanofi and AstraZeneca have tripled production capacity to meet growing demand. Beyfortus cut RSV hospitalizations by up to 83.2% and outperformed maternal vaccines in public health programs. Beginning in early […]

Image Credit: Adobe Stock Images/KevinRuck.com Key Takeaways To meet rising demand, Bora Pharmaceuticals is expanding its Baltimore facility by installing an automated vial, syringe, and cartridge line by 2026, enhancing its capabilities for small-scale, high-value drug production. The expansion supports increased demand for fill-finish services related to potent drugs and treatments for rare and orphan […]

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain Horizons 2025 Market Report. He identified several key reasons for this disconnect. First, many companies […]

Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization A Pharmaceutical Executive article explores how specialty pharmacy programs can significantly improve outcomes for patients with rare diseases—like cystic fibrosis—by providing faster access to treatment, better medication adherence, and personalized support that addresses the complex challenges of managing lifelong conditions. Rethinking Clinical Trial […]

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the US population affected, the issue is increasingly urgent, particularly as major chains like Rite Aid […]

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the US population affected, the issue is increasingly urgent, particularly as major chains like Rite Aid […]

Image Credit: Adobe Stock Images/Wladimir1804.com Key Takeaways MA enrollment among full-benefit dual-eligible beneficiaries is rising, reaching nearly 50% by 2022. FIDE-SNP enrollees have greater health and support needs than those in other MA plan types. FIDE-SNP enrollees are more likely to live in less disadvantaged areas, pointing to access disparities. Enrollment in Medicare Advantage (MA) […]

GLP-1 Drugs may be Linked to Elevated Risk of Serious Eye Disease, Study Finds A new observational study finds that people with diabetes taking GLP-1 drugs have a low but doubled risk of developing neovascular age-related macular degeneration, an eye disease that can cause blindness, highlighting the need for increased awareness and monitoring of eye […]